Impact of daily high-dose caffeine exposure on developing white matter of the immature ovine brain

Pediatric Research

Volumn 76, Issue 1, 2014, Pages 54-63

  Atik, Anzari ^a   Cheong, Jeanie ^b   Harding, Richard ^a   Rees, Sandra ^b   De Matteo, Robert ^a   Tolcos, Mary ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTOSIS; AUTOPSY; BRAIN DEVELOPMENT; BRAIN WEIGHT; CELL DENSITY; CONTROLLED STUDY; CORPUS STRIATUM; EXPERIMENTAL SHEEP; FETUS HEART RATE; GRAY MATTER; HEART RATE; MATERNAL PLASMA; MEAN ARTERIAL PRESSURE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; OXYGENATION; PRIORITY JOURNAL; WHITE MATTER;

ANIMALS; APOPTOSIS; AXONS; BRAIN; CAFFEINE; FEMALE; GLIOSIS; MATERNAL EXPOSURE; MYELIN BASIC PROTEIN; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA; PREGNANCY; PREGNANCY, ANIMAL; SHEEP; TIME FACTORS;

EID: 84902669870     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.55     Document Type: Article

References (38)

1. Martin RJ, Abu-Shaweesh JM, Baird TM. Apnoea of prematurity. Paediatr Respir Rev 2004;5 Suppl A:S377-S82.
2. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J 1981;17:273-6.
3. Abu-Shaweesh JM, Martin RJ. Neonatal apnea: whats new? Pediatr Pulmonol 2008;43:937-44.
4. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112-21.
5. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893-902.
6. Scanlon JE, Chin KC, Morgan ME, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline for neonatal apnoea? Arch Dis Child 1992;67:425-8.
7. Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI, Charles BG. Periextubation caffeine in preterm neonates: a randomized dose response trial. J Paediatr Child Health 2003;39:511-5.
8. Gray PH, Flenady VJ, Charles BG, Steer PA. Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J Paediatr Child Health 2011;47:167-72.
9. Juarez-Mendez S, Carretero R, Martinez-Tellez R, Silva-Gomez AB, Flores G. Neonatal caffeine administration causes a permanent increase in the dendritic length of prefrontal cortical neurons of rats. Synapse 2006;60:450-5.
10. Connolly S, Kingsbury TJ. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem Biophys Res Commun 2010;397:152-6.
11. Fuller GN, Divakaran P, Wiggins RC. The effect of postnatal caffeine administration on brain myelination. Brain Res 1982;249:189-91.
12. Desfrere L, Olivier P, Schwendimann L, Verney C, Gressens P. Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure. Pediatr Res 2007;62:604-9.
13. Rees S, Hale N, De Matteo R, et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury. J Neuropathol Exp Neurol 2010;69:306-19.
14. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC. Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 2002;61:197-211.
15. Back SA, Riddle A, Hohimer AR. Role of instrumented fetal sheep preparations in defining the pathogenesis of human periventricular white-matter injury. J Child Neurol 2006;21:582-9.
16. Roessmann U, Gambetti P. Pathological reaction of astrocytes in perinatal brain injury. Immunohistochemical study. Acta Neuropathol 1986;70:302-7.
17. Billiards SS, Haynes RL, Folkerth RD, et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 2006;497:199-208.
18. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302-12.
19. Roessmann U, Gambetti P. Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol 1986;70:308-13.
20. Haynes RL, Borenstein NS, Desilva TM, et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005;484:156-67.
21. Wilson SJ, Ayromlooi J, Errick JK. Pharmacokinetic and hemodynamic effects of caffeine in the pregnant sheep. Obstet Gynecol 1983;61:486-92.
22. Ikeda GJ, Sapienza PP, McGinnis ML, Bragg LE, Walsh JJ, Collins TF. Blood levels of caffeine and results of fetal examination after oral administration of caffeine to pregnant rats. J Appl Toxicol 1982;2:307-14.
23. Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 2007;119:936-40.
24. Leon AE, Michienzi K, Ma CX, Hutchison AA. Serum caffeine concentrations in preterm neonates. Am J Perinatol 2007;24:39-47.
25. Crossley KJ, Allison BJ, Polglase G, et al. Effects of caffeine on renal and pulmonary function in preterm newborn lambs. Pediatr Res 2012;72:19-25.
26. Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 2001;107:660-3.
27. Hoecker C, Nelle M, Beedgen B, Rengelshausen J, Linderkamp O. Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F61-F4.
28. Walther FJ, Erickson R, Sims ME. Cardiovascular effects of caffeine therapy in preterm infants. Am J Dis Child 1990;144:1164-6.
29. Marret S, Delpech B, Girard N, et al. Caffeine decreases glial cell number and increases hyaluronan secretion in newborn rat brain cultures. Pediatr Res 1993;34:716-9.
30. Tolcos M, Bateman E, ODowd R, et al. Intrauterine growth restriction affects the maturation of myelin. Exp Neurol 2011;232:53-65.
31. Doyle LW, Cheong J, Hunt RW, et al. Caffeine and brain development in very preterm infants. Ann Neurol 2010;68:734-42.
32. Heese K, Fiebich BL, Bauer J, Otten U. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett 1997;231:83-6.
33. Kang CH, Jayasooriya RG, Dilshara MG, et al. Caffeine suppresses lipopolysaccharide- stimulated BV2 microglial cells by suppressing Akt-mediated NF-êB activation and ERK phosphorylation. Food Chem Toxicol 2012;50:4270-6.
34. Kang SH, Lee YA, Won SJ, Rhee KH, Gwag BJ. Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. Neuroreport 2002;13:1945-50.
35. Black AM, Pandya S, Clark D, Armstrong EA, Yager JY. Effects of caffeine and morphine on the developing pre-mature brain. Brain Res 2008;1219:136-42.
36. Aranda JV, Cook CE, Gorman W, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979;94:663-8.
37. Fredholm BB. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93-101.
38. Stadelmann C, Lassmann H. Detection of apoptosis in tissue sections. Cell Tissue Res 2000;301:19-31.